Roadmap

The Medimint Roadmap outlines a strategic four-year trajectory, combining blockchain ecosystem maturity, healthcare infrastructure growth, and token economy stabilization. Each phase focuses on a measurable milestone — ensuring that the MDMT token value is tied directly to real-world machine activity, data flow, and ecosystem expansion.

Phase 1 — Foundation and Infrastructure Setup (Q1–Q2 2025)

Objective: Build the technological backbone and operational foundation for the Medimint ecosystem before token issuance.

Focus Area
Key Deliverables

Blockchain Development

  • Finalize Ethereum ERC-20 architecture for MDMT.

  • Develop smart contracts for staking, buyback, and yield mechanisms.

  • Initiate third-party smart contract audit for transparency.

Legal & Compliance

  • Complete KYC/AML framework and legal reviews for token issuance.

  • Ensure GDPR and HIPAA compliance for patient data management.

Hospital Network Onboarding

  • Onboard initial 50 hospitals across India and Africa.

  • Link first 100 diagnostic machines (MRI, CT, Ultrasound) to blockchain data flow.

Investor Preparation

  • Prepare investor materials, tokenomics whitepaper, and smart contract audit reports.

A fully functional blockchain prototype ready for internal testing and compliance validation. Medimint positions itself as a data-driven diagnostic blockchain network before the public token sale.

Phase 2 — Pre-Sale and Ecosystem Activation (Q3 2025)

Objective: Launch pre-sale, activate early investor ecosystem, and validate real-world machine integration.

Focus Area
Key Deliverables

Pre-Sale Launch

  • Conduct private + public pre-sale rounds at $0.10/token.

  • Target raise: $35 million USD.

  • 10% unlocked at TGE, rest vested over 18 months.

Ecosystem Activation

  • Deploy first batch of live yield-generating machines.

  • Establish real-time revenue tracking on Medimint dashboard.

  • Beta release of staking portal for early adopters.

Partnerships & Alliances

  • Partner with healthcare equipment OEMs and hospital chains.

  • Form technical collaborations with AI analytics and data processing firms.

Marketing & Awareness

  • Global campaign launch: “Healthcare Meets Blockchain.”

  • Host webinars, AMA sessions, and PR articles targeting investors and hospitals.

Community Building

  • Launch official Telegram, Discord, and X (Twitter) communities.

  • Onboard regional ambassadors in India, UAE, and Africa.

Outcome: Early investors gain entry at $0.10 while the ecosystem establishes its foundation with real yield proof from operating machines.

Phase 3 — Token Generation Event (TGE) and Exchange Listing (Q4 2025)

Objective: Launch MDMT Token on global exchanges, backed by real data and machine-driven value.

Focus Area
Key Deliverables

Token Launch (Conditional)

  • Launch MDMT Token (ERC-20) if market conditions are favorable.

  • Listing Price Target: $0.80 USD.

  • Initial circulation: 350M tokens.

Exchange Listing

  • Partner with Tier-1 and Tier-2 exchanges for liquidity pools.

  • Introduce liquidity management via market makers.

Yield Distribution Activation

  • Enable real-time staking and yield mechanisms.

  • Token holders begin earning profit-linked rewards.

Buyback & Liquidity Protocols

  • Initiate first buyback cycle using operational profits.

  • Deploy liquidity reserves (100M tokens) for trading depth.

Data Monetization Initiatives

  • Begin structuring anonymized diagnostic data streams for pharma R&D partnerships.

Platform Design

  • Complete Medimint web and mobile application UI/UX.

  • Integrate HL7 protocol for real-time machine data tracking.

  • Develop dashboards for investors and hospital partners.

A live, revenue-generating healthcare blockchain token — MDMT — with validated liquidity and yield distribution. The project establishes credibility through real-world backing and smart-contract transparency.

Phase 4 — Ecosystem Expansion and AI Integration (2026)

Objective: Scale operations, integrate AI analytics, and expand geographic reach.

Focus Area
Key Deliverables

Machine Pool Growth

  • Expand from 100 to 300 diagnostic machines globally.

  • Add genomics and PET-CT devices to the network.

AI & Predictive Analytics

  • Integrate AI modules for diagnostics and yield optimization.

  • Deploy predictive analytics dashboards for hospital partners.

Data Marketplace Launch

  • Launch Medimint Health Data Marketplace for pharma companies and research institutions.

  • Enable MDMT token payment for data access.

DAO Governance Implementation

  • Enable token-holder voting on profit allocation, buybacks, and new machine categories.

  • Introduce on-chain proposal and voting system.

Community Expansion

  • Reach 100K+ verified token holders.

  • Launch Medimint Ambassadors Program across 10 countries.

Medimint transitions into a fully autonomous, data-driven DAO ecosystem, with blockchainbased healthcare infrastructure and AI-powered data commercialization.


Phase 5 — Global Scaling and Institutional Integration (2027–2028)

Objective: Position Medimint as a global standard for blockchain-enabled healthcare infrastructure and tokenized diagnostics.

Focus Area
Key Deliverables

Geographic Expansion

  • Expand into GCC, Europe, and Southeast Asia.

  • Establish Medimint regional offices in UAE, Singapore, and US.

Institutional Integration

  • Partner with insurance companies, health ministries, and public health projects.

  • Integrate blockchain data into government-led health systems.

Token Utility Expansion

  • Enable patients to directly pay for healthcare services with MDMT tokens.

  • Allow hospitals to redeem tokens for machine upgrades and software services.

AI-Pharma Collaborations

  • Scale diagnostic data monetization for global pharmaceutical clients.

  • Use anonymized data for predictive drug discovery and clinical trials.

Ecosystem Renewal Model

  • Begin 5-year machine lifecycle renewal process.

  • Burn obsolete tokens and reissue for newly onboarded assets.

Outcome: Medimint becomes the world’s first decentralized diagnostic infrastructure token, bridging healthcare operations, blockchain finance, and biomedical data.


Phase 6 — Long-Term Sustainability and DAO Governance (Post-2028)

Objective: Achieve full decentralization and continuous yield economy backed by global healthcare participation.

Focus Area
Key Deliverables

Fully Decentralized DAO

  • Token holders control yield rates, treasury use, and future expansions.

Sustainable Yield Model

  • Maintain continuous profit-sharing cycles from hospital revenues.

Deflationary Supply Management

  • DAO votes on periodic buybacks and burn schedules to balance supply and value.

Ecosystem Renewal

  • Replace old machine pools with next-generation diagnostics.

  • Reinforce ecosystem growth without token inflation.

Outcome: A self-sustaining, decentralized healthcare blockchain where token holders, hospitals, and partners share real, measurable value through data-driven healthcare performance.


Key Milestone Summary

Year
Milestone
Target Outcome

2025 (Q1– Q4)

Blockchain Development + Pre-Sale + TGE

Establish core infrastructure and launch MDMT token

2026

AI & Data Marketplace Launch

Token utility expands into healthcare data and AI analytics

2027

Global Expansion + DAO Governance

Ecosystem scales to 5 countries and DAO control initiated

2028

Token Renewal + Deflationary Burn

Machine renewal cycle initiates and sustainable yield model matures

Last updated